Table 3.
Compound | Reference | External dose (mg/kg body weight/d) | Concentration at end of the study (mg/mL) | ||
---|---|---|---|---|---|
Modeled | Reported mean | Ratio | |||
PFBS | NTP99 | 62.6 | 3.7 | 2.2 | 1.3 |
125 | 7.4 | 5.3 | 1.4 | ||
250 | 15 | 12 | 1.3 | ||
500 | 30 | 43 | 0.7 | ||
PFHxS | NTP99 | 0.625 | 71 | 66 | 1.1 |
1.25 | 140 | 92 | 1.5 | ||
2.5 | 280 | 130 | 2.2 | ||
5 | 570 | 160 | 3.6 | ||
10 | 1,100 | 200 | 5.5 | ||
PFOS | NTP99 | 0.312 | 13 | 24 | 0.5 |
0.625 | 26 | 52 | 0.5 | ||
1.25 | 52 | 94 | 0.6 | ||
2.5 | 100 | 170 | 0.6 | ||
5 | 210 | 320 | 0.7 | ||
PFHxA | NTP100 | 62.6 | 1 | 0.38 | 2.6 |
125 | 2 | 0.50 | 4.0 | ||
250 | 4 | 1.3 | 3.1 | ||
500 | 8.1 | 3.4 | 2.4 | ||
1,000 | 16 | 11 | 1.5 | ||
PFOA | NTP100 | 0.625 | 48 | 51 | 0.9 |
1.25 | 96 | 73 | 1.3 | ||
2.5 | 190 | 95 | 2.0 | ||
5 | 380 | 110 | 3.5 | ||
10 | 770 | 150 | 5.1 | ||
PFNA | NTP100 | 0.625 | 95 | 57 | 1.7 |
1.25 | 190 | 160 | 1.2 | ||
2.5 | 380 | 380 | 1.0 | ||
5 | 760 | 360 | 2.1 | ||
PFDA | NTP100 | 0.156 | 9 | 8.5 | 1.1 |
0.312 | 18 | 23 | 0.8 | ||
0.625 | 36 | 43 | 0.8 | ||
1.25 | 72 | 100 | 0.7 | ||
2.5 | 140 | 260 | 0.5 |
Note: NTP, National Toxicology Program; PFBS, perfluorobutane sulfonic acid; PFDA, perfluorodecanoic acid; PFHxA, perfluorohexanoic acid; PFHxS, perfluorohexane sulfonic acid; PFNA, perfluorononanoic acid; PFOA, perfluorooctanoic acid; PFOS, perfluorooctane sulfonic acid.